Comparative Pharmacology
Head-to-head clinical analysis: AVERI versus AVIANE 21.
Peer-Reviewed Evidence
Head-to-head clinical analysis: AVERI versus AVIANE 21.
AVERI vs AVIANE-21
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
AVERI (avacincaptad pegol) is a pegylated RNA aptamer that binds to complement component C5, inhibiting its cleavage into C5a and C5b and thereby preventing downstream complement pathway activation.
Combination estrogen-progestin contraceptive; inhibits gonadotropin secretion, suppressing ovulation; increases cervical mucus viscosity, impeding sperm penetration; alters endometrial receptivity.
150 mg orally once daily
One tablet orally once daily for 21 consecutive days, followed by 7 drug-free days. Each tablet contains levonorgestrel 0.1 mg and ethinyl estradiol 0.02 mg.
None Documented
None Documented
Terminal elimination half-life is 12 hours; in renal impairment (CrCl < 30 mL/min), half-life extends to 24 hours, requiring dose adjustment.
Clinical Note
moderatePinaverium + Erythromycin
"The metabolism of Erythromycin can be decreased when combined with Pinaverium."
Clinical Note
moderatePinaverium + Fluconazole
"The serum concentration of Fluconazole can be increased when it is combined with Pinaverium."
Clinical Note
moderatePinaverium + Clarithromycin
"The metabolism of Clarithromycin can be decreased when combined with Pinaverium."
Clinical Note
moderatePinaverium + Lovastatin
Levonorgestrel: terminal half-life 27.7 ± 7.2 hours; ethinyl estradiol: terminal half-life 15.4 ± 8.4 hours. Steady-state achieved within 7–14 days.
Renal excretion accounts for 60% (20% unchanged, 40% as metabolites); biliary/fecal excretion accounts for 30%.
Renal (primarily as metabolites, ~60%), fecal (~40%), with less than 10% excreted unchanged as ethinyl estradiol and levonorgestrel.
Category C
Category C
Contraceptive (Hormonal)
Contraceptive (Hormonal)
"The risk or severity of adverse effects can be increased when Pinaverium is combined with Lovastatin."